Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001266260 | SCV001444433 | pathogenic | Inborn genetic diseases | 2018-03-12 | criteria provided, single submitter | clinical testing | |
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV002254342 | SCV002525579 | pathogenic | not provided | 2020-12-14 | criteria provided, single submitter | clinical testing | This variant has not been observed in large population studies (Genome Aggregation Database v2.1.1). This variant has also not been reported in the medical literature or ClinVar database in clinically affected individuals. This variant is predicted to create a premature termination codon at protein position 233 (of 549 total amino acids). The truncated protein would lack the C-terminal ERK interaction and repressor domains. While the ERF p.Arg233* variant has not been reported before, other nearby protein-truncating variants have been reported in affected individuals. |
Tartaglia Lab, |
RCV004587095 | SCV004229151 | pathogenic | Noonan Syndrome-like developmental disorder | 2023-12-31 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV004762040 | SCV005368270 | pathogenic | Craniosynostosis 4 | 2024-08-12 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PS4_SUP,PM2_SUP |